Back to today’s briefing

Story perspectives

Universal Genetic Testing Boosts Colorectal Cancer Diagnoses

6/18/2025

35 7

Summary

Story summary

A groundbreaking Yale study reveals a startling truth: only 28% to 45% of colorectal cancer patients undergo genetic testing for Lynch syndrome, a hereditary cancer risk. However, implementing universal upfront genetic testing proves not only cost-effective but also significantly boosts diagnoses, paving the way for vital preventive measures for patients and their families.

1 of 1

Story summary

A groundbreaking Yale study reveals a startling truth: only 28% to 45% of colorectal cancer patients undergo genetic testing for Lynch syndrome, a hereditary cancer risk. However, implementing universal upfront genetic testing proves not only cost-effective but also significantly boosts diagnoses, paving the way for vital preventive measures for patients and their families.